Rxsight Stock Performance
| RXST Stock | USD 7.82 0.12 1.51% |
The company holds a Beta of 0.35, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Rxsight's returns are expected to increase less than the market. However, during the bear market, the loss of holding Rxsight is expected to be smaller as well. At this point, Rxsight has a negative expected return of -0.34%. Please make sure to check Rxsight's maximum drawdown, daily balance of power, as well as the relationship between the Daily Balance Of Power and period momentum indicator , to decide if Rxsight performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Rxsight has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in March 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return 7.29 | Five Day Return (5.84) | Year To Date Return (19.17) | Ten Year Return (47.56) | All Time Return (47.56) |
1 | Squarepoint Ops LLC Raises Stock Holdings in RxSight, Inc. RXST - MarketBeat | 12/16/2025 |
2 | RxSight Announces CFO Transition and Leadership Continuity Plan - TipRanks | 12/23/2025 |
3 | RxSight, Inc. Receives Average Recommendation of Reduce from Brokerages - MarketBeat | 12/31/2025 |
4 | Income Plays Will RxSight Inc stock outperform value stocks - Earnings Growth Summary Low Risk High Win Rate Picks - moha.gov.vn | 01/05/2026 |
5 | Acquisition by Mark Wilterding of 163528 shares of Rxsight subject to Rule 16b-3 | 01/12/2026 |
6 | INVESTOR ALERT Pomerantz Law Firm Investigates Claims On Behalf of Investors of RxSight, Inc. - RXST | 01/15/2026 |
7 | Baillie Gifford Co. Raises Stock Holdings in RxSight, Inc. RXST - MarketBeat | 01/26/2026 |
8 | Acquisition by Andrews Julie of 10752 shares of Rxsight subject to Rule 16b-3 | 02/04/2026 |
| Begin Period Cash Flow | 10.4 M | |
| Total Cashflows From Investing Activities | -99.3 M |
Rxsight Relative Risk vs. Return Landscape
If you would invest 1,011 in Rxsight on November 9, 2025 and sell it today you would lose (229.00) from holding Rxsight or give up 22.65% of portfolio value over 90 days. Rxsight is currently does not generate positive expected returns and assumes 4.0388% risk (volatility on return distribution) over the 90 days horizon. In different words, 36% of stocks are less volatile than Rxsight, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Rxsight Target Price Odds to finish over Current Price
The tendency of Rxsight Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 7.82 | 90 days | 7.82 | roughly 97.0 |
Based on a normal probability distribution, the odds of Rxsight to move above the current price in 90 days from now is roughly 97.0 (This Rxsight probability density function shows the probability of Rxsight Stock to fall within a particular range of prices over 90 days) .
Rxsight Price Density |
| Price |
Predictive Modules for Rxsight
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Rxsight. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Rxsight's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Rxsight Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Rxsight is not an exception. The market had few large corrections towards the Rxsight's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Rxsight, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Rxsight within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.13 | |
β | Beta against Dow Jones | 0.35 | |
σ | Overall volatility | 1.40 | |
Ir | Information ratio | -0.04 |
Rxsight Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Rxsight for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Rxsight can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Rxsight generated a negative expected return over the last 90 days | |
| Rxsight has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 139.93 M. Net Loss for the year was (27.45 M) with profit before overhead, payroll, taxes, and interest of 106.53 M. | |
| Rxsight currently holds about 128.62 M in cash with (16.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.65. | |
| Over 83.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by Andrews Julie of 10752 shares of Rxsight subject to Rule 16b-3 |
Rxsight Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Rxsight Stock often depends not only on the future outlook of the current and potential Rxsight's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Rxsight's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 38.9 M | |
| Cash And Short Term Investments | 237.2 M |
Rxsight Fundamentals Growth
Rxsight Stock prices reflect investors' perceptions of the future prospects and financial health of Rxsight, and Rxsight fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Rxsight Stock performance.
| Return On Equity | -0.13 | ||||
| Return On Asset | -0.0919 | ||||
| Profit Margin | (0.25) % | ||||
| Operating Margin | (0.40) % | ||||
| Current Valuation | 110.52 M | ||||
| Shares Outstanding | 41.12 M | ||||
| Price To Earning | 42.55 X | ||||
| Price To Book | 1.18 X | ||||
| Price To Sales | 2.26 X | ||||
| Revenue | 139.93 M | ||||
| Gross Profit | 106.53 M | ||||
| EBITDA | (23.76 M) | ||||
| Net Income | (27.45 M) | ||||
| Cash And Equivalents | 128.62 M | ||||
| Cash Per Share | 4.65 X | ||||
| Total Debt | 12.3 M | ||||
| Debt To Equity | 0.41 % | ||||
| Current Ratio | 11.54 X | ||||
| Book Value Per Share | 6.72 X | ||||
| Cash Flow From Operations | (16.95 M) | ||||
| Earnings Per Share | (0.88) X | ||||
| Market Capitalization | 321.53 M | ||||
| Total Asset | 318.56 M | ||||
| Retained Earnings | (622.1 M) | ||||
| Working Capital | 267.95 M | ||||
About Rxsight Performance
Assessing Rxsight's fundamental ratios provides investors with valuable insights into Rxsight's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Rxsight is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 225.41 | 296.29 | |
| Return On Tangible Assets | (0.10) | (0.09) | |
| Return On Capital Employed | (0.11) | (0.12) | |
| Return On Assets | (0.10) | (0.09) | |
| Return On Equity | (0.09) | (0.09) |
Things to note about Rxsight performance evaluation
Checking the ongoing alerts about Rxsight for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Rxsight help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Rxsight generated a negative expected return over the last 90 days | |
| Rxsight has high historical volatility and very poor performance | |
| The company reported the previous year's revenue of 139.93 M. Net Loss for the year was (27.45 M) with profit before overhead, payroll, taxes, and interest of 106.53 M. | |
| Rxsight currently holds about 128.62 M in cash with (16.95 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 4.65. | |
| Over 83.0% of the company shares are owned by institutional investors | |
| Latest headline from MacroaxisInsider: Acquisition by Andrews Julie of 10752 shares of Rxsight subject to Rule 16b-3 |
- Analyzing Rxsight's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Rxsight's stock is overvalued or undervalued compared to its peers.
- Examining Rxsight's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Rxsight's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Rxsight's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Rxsight's stock. These opinions can provide insight into Rxsight's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Rxsight Stock Analysis
When running Rxsight's price analysis, check to measure Rxsight's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Rxsight is operating at the current time. Most of Rxsight's value examination focuses on studying past and present price action to predict the probability of Rxsight's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Rxsight's price. Additionally, you may evaluate how the addition of Rxsight to your portfolios can decrease your overall portfolio volatility.